title: Appropriateness of transfusions of red cells, platelets and fresh frozen plasma. An audit in a tertiary care teaching hospital.
abstract: OBJECTIVE
  To determine how current hospital practice for transfusions of red cells, platelets and fresh frozen plasma conformed with published criteria.
  
  
  METHODS
  Elaboration of criteria for transfusion from a review of the current literature; and analysis of the medical records of patients receiving transfusions of red cells (200), platelets (215), and fresh frozen plasma (260) during defined time periods in 1993.
  
  
  METHODS
  A large tertiary care teaching hospital.
  
  
  METHODS
  Inappropriateness rates for transfusion episodes and numbers of individual units of blood products administered.
  
  
  RESULTS
  Inappropriateness rates for transfusion episodes and numbers of individual units administered were 16% and 10% for red cells, 13% and 11% for platelets, and 24% and 16% for fresh frozen plasma (31% and 21% when transfusions for thrombotic thrombocytopenic purpura were excluded). Red cells and fresh frozen plasma were used inappropriately most frequently in association with a surgical procedure; for platelets, it was their use for bleeding. In many of the transfusions deemed inappropriate, deficiencies of red cells, platelets and/or coagulation factors were documented, but the degree of deficiency did not meet the stringent appropriateness criteria. Twenty-six transfusions were deemed inappropriate because the indication was not documented in the medical record.
  
  
  CONCLUSIONS
  Specific problem areas in which blood product use was inappropriate were identified. Guidelines for transfusion appropriateness, education of hospital staff, and a monitoring system to ensure adherence to the guidelines, are required.
authors.affiliation: Royal Melbourne Hospital, Melbourne, VIC.
authors.forename: J
authors.initials: J
authors.lastname: Metz
authors.forename: K M
authors.initials: KM
authors.lastname: McGrath
authors.forename: M L
authors.initials: ML
authors.lastname: Copperchini
authors.forename: M
authors.initials: M
authors.lastname: Haeusler
authors.forename: H E
authors.initials: HE
authors.lastname: Haysom
authors.forename: P R
authors.initials: PR
authors.lastname: Gibson
authors.forename: R J
authors.initials: RJ
authors.lastname: Millar
authors.forename: A
authors.initials: A
authors.lastname: Babarczy
authors.forename: L
authors.initials: L
authors.lastname: Ferris
authors.forename: A P
authors.initials: AP
authors.lastname: Grigg
mesh_terms: D000740:Anemia / Q000628:therapy; D000755:Anemia, Sickle Cell / Q000628:therapy; D001780:Blood Coagulation Tests; D016063:Blood Loss, Surgical / Q000517:prevention & control; D001803:Blood Transfusion / Q000706:statistics & numerical data*; D017707:Erythrocyte Transfusion / Q000706:statistics & numerical data*; D006470:Hemorrhage / Q000628:therapy; D006784:Hospitals, Teaching; D006801:Humans; D008485:Medical Audit; D010949:Plasma; D017713:Platelet Transfusion / Q000706:statistics & numerical data*; D011697:Purpura, Thrombotic Thrombocytopenic / Q000628:therapy; D012040:Regional Health Planning; D012189:Retrospective Studies; D013921:Thrombocytopenia / Q000628:therapy; D014739:Victoria / Q000453:epidemiology